Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 211

Results For "NCEs"

2270 News Found

Curadev Pharma partners with CMC Vellore for dengue research
Healthcare | November 11, 2021

Curadev Pharma partners with CMC Vellore for dengue research

The company will provide the technical and financial resources to support the study


Pulmatrix resolves dispute with Cipla
News | November 10, 2021

Pulmatrix resolves dispute with Cipla

Cipla Technologies a subsidiary of Cipla and Pulmatrix had inked a definitive agreement for the co-development and commercialisation of Pulmazole.


Amneal Pharmaceuticals acquires Puniska Healthcare for Rs 700 crore
News | November 09, 2021

Amneal Pharmaceuticals acquires Puniska Healthcare for Rs 700 crore

The company has operations in North America, Asia, and Europe,


St. George’s University School of Medicine to host a webinar for aspiring doctors
Events | November 05, 2021

St. George’s University School of Medicine to host a webinar for aspiring doctors

The students can interact with resident doctors and graduates of SGU


Novartis AG wins case against four domestic pharma firms
News | November 03, 2021

Novartis AG wins case against four domestic pharma firms

The injunction order has been passed against Natco Pharma, Torrent Pharmaceuticals, Eris Lifesciences and Windlas Biotech


Lonza to acquire Exosomics service unit in Italy
Biotech | November 03, 2021

Lonza to acquire Exosomics service unit in Italy

Expertise in exosomes isolation and characterization will drive innovation in this field


Lancet endorses Sputnik Light for safety and immune response
News | November 03, 2021

Lancet endorses Sputnik Light for safety and immune response

Sputnik Light has been authorised in more than 15 countries with the registration process ongoing in a further 30 countries


SOPHiA Genetics launches SOPHiA DDM to assist Agilent customers
Digitisation | November 02, 2021

SOPHiA Genetics launches SOPHiA DDM to assist Agilent customers

New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation


AstraZeneca to transfer global rights for Eklira and Duaklir to Covis Pharma
Biotech | November 02, 2021

AstraZeneca to transfer global rights for Eklira and Duaklir to Covis Pharma

The agreement sharpens the company’s focus on priority medicines in respiratory & immunology portfolio


Sun Pharma's Winlevi available in the US
Drug Approval | November 01, 2021

Sun Pharma's Winlevi available in the US

It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years